CURAPATH Trademark

Trademark Overview


On Thursday, August 4, 2022, a trademark application was filed for CURAPATH with the United States Patent and Trademark Office. The USPTO has given the CURAPATH trademark a serial number of 97534202. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, August 23, 2024. This trademark is owned by Polypeptide Therapeutic Solutions USA LLC. The CURAPATH trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Custom manufacture of polyamino acid based and nanoparticle based biopharmaceutical preparations for purposes of scientific and medical research and for therapeutic purposes

Biopharmaceutical preparations, namely, polyamino acid based therapeutics, polymer, and lipid based pharmaceutical preparations for the treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, genetic and immune system related diseases and disorders

Regulatory compliance consulting services in the biotechnology fields, namely, reviewing standards and practices and assisting third parties with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology

Consulting services in the fields of biotechnology, pharmaceutical research and development of polyamino acid based and nanoparticle molecules for research, drug, vaccine, and therapeutic product use; product research and development for use in manufacturing of polyamino acid based and nanoparticle molecules; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biotechnology and polyamino acid based and nanoparticle molecules
curapath

General Information


Serial Number97534202
Word MarkCURAPATH
Filing DateThursday, August 4, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, August 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements


Goods and ServicesCustom manufacture of polyamino acid based and nanoparticle based biopharmaceutical preparations for purposes of scientific and medical research and for therapeutic purposes
Goods and ServicesBiopharmaceutical preparations, namely, polyamino acid based therapeutics, polymer, and lipid based pharmaceutical preparations for the treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, genetic and immune system related diseases and disorders
Goods and ServicesRegulatory compliance consulting services in the biotechnology fields, namely, reviewing standards and practices and assisting third parties with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development of polyamino acid based and nanoparticle molecules for research, drug, vaccine, and therapeutic product use; product research and development for use in manufacturing of polyamino acid based and nanoparticle molecules; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biotechnology and polyamino acid based and nanoparticle molecules

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePolypeptide Therapeutic Solutions USA LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Francisco, CA 94111

Party NamePolypeptide Therapeutic Solutions USA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Francisco, CA 94111

Trademark Events


Event DateEvent Description
Monday, August 8, 2022NEW APPLICATION ENTERED
Thursday, August 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 23, 2023ASSIGNED TO EXAMINER
Thursday, May 25, 2023NON-FINAL ACTION WRITTEN
Thursday, May 25, 2023NON-FINAL ACTION E-MAILED
Thursday, May 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 18, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, August 18, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, November 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, August 23, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 23, 2024SOU EXTENSION 1 GRANTED
Friday, August 23, 2024SOU EXTENSION 1 FILED
Tuesday, February 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT